MERRIMACK PHARMACEUTICALS
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, design, and development of therapies for the treatment of diseases in the areas of autoimmunity and cancer. It develops MM-093, a human alpha-fetoprotein for the treatment of patients with rheumatoid arthritis and psoriasis; and MM-121, a human monoclonal antibody and therapeutic to block signaling of the ErbB3 receptor. Merrimack Pharmaceuticals, Inc. was formerly known as Atlantic BioPharmaceuticals, Inc. The company was founded in 1993 and is based in Cambridge, Massachusetts.
MERRIMACK PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2000-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.merrimack.com
Total Employee:
251+
Status:
Active
Contact:
(617) 441-1000
Email Addresses:
[email protected]
Total Funding:
288.01 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Google Google Cloud Microsoft GoDaddy SSL Vimeo Microsoft Azure
Similar Organizations
7 Hills Pharma
7 Hills Pharma is developing novel immunotherapies for the treatment Of cancer.
AcelRx Pharmaceuticals
AcelRx Pharmaceuticals focuses on the development and commercialization of therapies for the treatment of pain and other conditions.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Anthera Pharmaceuticals
Anthera Pharmaceuticals is focused on developing products to treat diseases associated with inflammation and autoimmune diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aragon Pharmaceuticals
Aragon Pharmaceuticals develops therapeutics for the treatment of hormone-resistant cancers such as prostate and breast cancer.
Arizona Humane Society
Arizona Humane Society saves the most vulnerable animals and enriches the lives of pets and people.
Athersys
Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications.
Benaroya Research Institute
Benaroya Research Institute at Virginia Mason is devoted to finding causes and cures for autoimmune diseases.
BioNumerik Pharmaceuticals
BioNumerik Pharmaceuticals discovers, develops and commercializes drugs for treating cancer.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
FogPharma
FogPharma creates a new class of medicines that target human disease drivers currently considered undruggable.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Ista Pharmaceuticals
ISTA Pharmaceuticals discovers, develops, and markets remedies for diseases and conditions of the eye in the United States.
ORCA Therapeutics
ORCA Therapeutics isdesigns and develops therapeutics for the treatment of cancer using Oncolytic Replication Competent Agents (ORCA).
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
ROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Sprout Pharmaceuticals
Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
TetraLogic Pharmaceuticals
TetraLogic Pharmaceuticals discovers and develops small molecule drugs for the treatment of debilitating diseases and conditions.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Merrimack Pharmaceuticals
TPG-Axon Capital
TPG-Axon Capital investment in Private Equity Round - Merrimack Pharmaceuticals
Credit Suisse
Credit Suisse investment in Private Equity Round - Merrimack Pharmaceuticals
Jennison Associates
Jennison Associates investment in Private Equity Round - Merrimack Pharmaceuticals
WT Investment Advisors Fund
WT Investment Advisors Fund investment in Private Equity Round - Merrimack Pharmaceuticals
Crocker Ventures
Crocker Ventures investment in Private Equity Round - Merrimack Pharmaceuticals
Sorenson Development
Sorenson Development investment in Series E - Merrimack Pharmaceuticals
Jennison Associates
Jennison Associates investment in Series E - Merrimack Pharmaceuticals
TPG-Axon Capital
TPG-Axon Capital investment in Series E - Merrimack Pharmaceuticals
WT Investment Advisors Fund
WT Investment Advisors Fund investment in Series E - Merrimack Pharmaceuticals
Official Site Inspections
http://www.merrimack.com
- Host name: 209.182.196.37
- IP address: 209.182.196.37
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
